What’s in a Name (or an Acronym)?
or Jason. Once named our aches, pains and pathologies are noticeably softened and more readily accepted. We infer that someone, somewhere has identified, studied, and perhaps cured the pathology, an inference consistent with investment folklore that the greatest opportunities occur before an asset class
or strategy has been named. How re-assuringly benign and trustworthy are strategies pre-fixed by ‘enhanced’, ‘structured’, ‘protected’, and ‘balanced’? In Germany die Stratacticalstructuredquantamentalenhancedich
would surely induce a calming comfort and inspire trust. (more…)
In this article, Ed Peters, co-director of global macro at First Quadrant, Ed Peters, examines what markets, or betas, are essential to fully diversitfy a global portfolio, while still achieving long-term goals; and how breadth is often confused with diversification.